Search Tag: HCC imaging
2025 10 Nov
Hepatocellular carcinoma (HCC) presents with marked biological diversity that shapes prognosis, treatment sensitivity and risk of recurrence. Molecular and pathological classifications capture this heterogeneity but usually rely on tissue sampling that is invasive, prone to sampling error and often unavailable when therapy is chosen. Increasing...Read more
2025 10 Nov
Hepatocellular carcinoma (HCC) presents with marked biological diversity that shapes prognosis, treatment sensitivity and risk of recurrence. Molecular and pathological classifications capture this heterogeneity but usually rely on tissue sampling that is invasive, prone to sampling error and often unavailable when therapy is chosen. Increasing...Read more
2025 25 Aug
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, with significant challenges in diagnosis, risk stratification and treatment selection. While imaging has long been a cornerstone of HCC diagnosis, emerging evidence supports its role in identifying prognostic and predictive markers. These markers offer...Read more
2025 25 Aug
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, with significant challenges in diagnosis, risk stratification and treatment selection. While imaging has long been a cornerstone of HCC diagnosis, emerging evidence supports its role in identifying prognostic and predictive markers. These markers offer...Read more
2024 16 Dec
Liver diseases, characterised by their chronic progression and often asymptomatic nature, present a significant challenge to global healthcare systems. Conditions such as liver cirrhosis and hepatocellular carcinoma (HCC) often progress silently until they reach advanced stages, making timely and accurate diagnosis critical. Artificial intelligence...Read more